APO Research

APO RESEARCH · REPORT

Drug Detection and Analysis

Selected research

Market Structure

Global Drug Detection and Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Drug Detection and Analysis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drug Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug Detection and Analysis include Eurofins Scientific, SGS, Labcorp, Intertek, WuXi AppTec, Charles River Laboratories, ICON pIc, IQVIA and Medpace, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Drug Detection and Analysis market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Detection and Analysis and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Detection and Analysis revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drug Detection and Analysis market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug Detection and Analysis Segment by Company

Eurofins Scientific

SGS

Labcorp

Intertek

WuXi AppTec

Charles River Laboratories

ICON pIc

IQVIA

Medpace

Syneos Health

Frontage Laboratories

Pace Analytical Services

Element Materials Technology

ALS Limited

STERIS

LGC Limited

Almac Group

Catalent

Cambrex

Alcami

Toxikon

Boston Analytical

Drug Detection and Analysis Segment by Type

Chemical Drug Testing

Biopharmaceutical Testing

Traditional Chinese Medicine Testing

Others

Drug Detection and Analysis Segment by Application

Pharmaceutical Companies

Biopharmaceutical Companies

Drug Regulatory Authorities

Others

Drug Detection and Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Detection and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Detection and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Detection and Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drug Detection and Analysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Detection and Analysis industry.

Chapter 3: Detailed analysis of Drug Detection and Analysis companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Detection and Analysisrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Detection and Analysis Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Chemical Drug Testing Table 3. Key Players of Biopharmaceutical Testing Table 4. Key Players of Traditional Chinese Medicine Testing Table 3. Key Players of Others Table 4. Global Drug Detection and Analysis Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Companies Table 6. Key Players of Biopharmaceutical Companies Table 7. Key Players of Drug Regulatory Authorities Table 8. Key Players of Others Table 9. Global Drug Detection and Analysis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Drug Detection and Analysis Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Drug Detection and Analysis Market Share by Region (2021-2026) Table 12. Global Drug Detection and Analysis Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Drug Detection and Analysis Market Share by Region (2027-2032) Table 14. Drug Detection and Analysis Industry Trends Table 15. Drug Detection and Analysis Industry Drivers Table 16. Drug Detection and Analysis Industry Opportunities and Challenges Table 17. Drug Detection and Analysis Industry Restraints Table 18. Global Drug Detection and Analysis Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Drug Detection and Analysis Revenue Market Share by Company (2021-2026) Table 20. Global Drug Detection and Analysis Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Drug Detection and Analysis Key Company Head Office and Area Served Table 22. Global Drug Detection and Analysis Company, Product Type & Application Table 23. Global Drug Detection and Analysis Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Drug Detection and Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Drug Detection and Analysis Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Drug Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Drug Detection and Analysis Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Drug Detection and Analysis Revenue Market Share by Type (2021-2026) Table 30. Global Drug Detection and Analysis Revenue Market Share by Type (2027-2032) Table 31. Global Drug Detection and Analysis Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Drug Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Drug Detection and Analysis Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Drug Detection and Analysis Revenue Market Share by Application (2021-2026) Table 35. Global Drug Detection and Analysis Revenue Market Share by Application (2027-2032) Table 36. Eurofins Scientific Company Information Table 37. Eurofins Scientific Business Overview Table 38. Eurofins Scientific Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Eurofins Scientific Drug Detection and Analysis Product Portfolio Table 40. Eurofins Scientific Recent Development Table 41. SGS Company Information Table 42. SGS Business Overview Table 43. SGS Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. SGS Drug Detection and Analysis Product Portfolio Table 45. SGS Recent Development Table 46. Labcorp Company Information Table 47. Labcorp Business Overview Table 48. Labcorp Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Labcorp Drug Detection and Analysis Product Portfolio Table 50. Labcorp Recent Development Table 51. Intertek Company Information Table 52. Intertek Business Overview Table 53. Intertek Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Intertek Drug Detection and Analysis Product Portfolio Table 55. Intertek Recent Development Table 56. WuXi AppTec Company Information Table 57. WuXi AppTec Business Overview Table 58. WuXi AppTec Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. WuXi AppTec Drug Detection and Analysis Product Portfolio Table 60. WuXi AppTec Recent Development Table 61. Charles River Laboratories Company Information Table 62. Charles River Laboratories Business Overview Table 63. Charles River Laboratories Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Charles River Laboratories Drug Detection and Analysis Product Portfolio Table 65. Charles River Laboratories Recent Development Table 66. ICON pIc Company Information Table 67. ICON pIc Business Overview Table 68. ICON pIc Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. ICON pIc Drug Detection and Analysis Product Portfolio Table 70. ICON pIc Recent Development Table 71. IQVIA Company Information Table 72. IQVIA Business Overview Table 73. IQVIA Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. IQVIA Drug Detection and Analysis Product Portfolio Table 75. IQVIA Recent Development Table 76. Medpace Company Information Table 77. Medpace Business Overview Table 78. Medpace Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Medpace Drug Detection and Analysis Product Portfolio Table 80. Medpace Recent Development Table 81. Syneos Health Company Information Table 82. Syneos Health Business Overview Table 83. Syneos Health Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Syneos Health Drug Detection and Analysis Product Portfolio Table 85. Syneos Health Recent Development Table 86. Frontage Laboratories Company Information Table 87. Frontage Laboratories Business Overview Table 88. Frontage Laboratories Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Frontage Laboratories Drug Detection and Analysis Product Portfolio Table 90. Frontage Laboratories Recent Development Table 91. Pace Analytical Services Company Information Table 92. Pace Analytical Services Business Overview Table 93. Pace Analytical Services Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Pace Analytical Services Drug Detection and Analysis Product Portfolio Table 95. Pace Analytical Services Recent Development Table 96. Element Materials Technology Company Information Table 97. Element Materials Technology Business Overview Table 98. Element Materials Technology Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Element Materials Technology Drug Detection and Analysis Product Portfolio Table 100. Element Materials Technology Recent Development Table 101. ALS Limited Company Information Table 102. ALS Limited Business Overview Table 103. ALS Limited Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. ALS Limited Drug Detection and Analysis Product Portfolio Table 105. ALS Limited Recent Development Table 106. STERIS Company Information Table 107. STERIS Business Overview Table 108. STERIS Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. STERIS Drug Detection and Analysis Product Portfolio Table 110. STERIS Recent Development Table 111. LGC Limited Company Information Table 112. LGC Limited Business Overview Table 113. LGC Limited Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. LGC Limited Drug Detection and Analysis Product Portfolio Table 115. LGC Limited Recent Development Table 116. Almac Group Company Information Table 117. Almac Group Business Overview Table 118. Almac Group Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Almac Group Drug Detection and Analysis Product Portfolio Table 120. Almac Group Recent Development Table 121. Catalent Company Information Table 122. Catalent Business Overview Table 123. Catalent Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Catalent Drug Detection and Analysis Product Portfolio Table 125. Catalent Recent Development Table 126. Cambrex Company Information Table 127. Cambrex Business Overview Table 128. Cambrex Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Cambrex Drug Detection and Analysis Product Portfolio Table 130. Cambrex Recent Development Table 131. Alcami Company Information Table 132. Alcami Business Overview Table 133. Alcami Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. Alcami Drug Detection and Analysis Product Portfolio Table 135. Alcami Recent Development Table 136. Toxikon Company Information Table 137. Toxikon Business Overview Table 138. Toxikon Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 139. Toxikon Drug Detection and Analysis Product Portfolio Table 140. Toxikon Recent Development Table 141. Boston Analytical Company Information Table 142. Boston Analytical Business Overview Table 143. Boston Analytical Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 144. Boston Analytical Drug Detection and Analysis Product Portfolio Table 145. Boston Analytical Recent Development Table 146. North America Drug Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 147. North America Drug Detection and Analysis Market Size by Type (2027-2032) & (US$ Million) Table 148. North America Drug Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 149. North America Drug Detection and Analysis Market Size by Application (2027-2032) & (US$ Million) Table 150. North America Drug Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. North America Drug Detection and Analysis Market Size by Country (2021-2026) Table 152. North America Drug Detection and Analysis Market Size by Country (2027-2032) Table 153. Europe Drug Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 154. Europe Drug Detection and Analysis Market Size by Type (2027-2032) & (US$ Million) Table 155. Europe Drug Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 156. Europe Drug Detection and Analysis Market Size by Application (2027-2032) & (US$ Million) Table 157. Europe Drug Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Drug Detection and Analysis Market Size by Country (2021-2026) Table 159. Europe Drug Detection and Analysis Market Size by Country (2027-2032) Table 160. China Drug Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 161. China Drug Detection and Analysis Market Size by Type (2027-2032) & (US$ Million) Table 162. China Drug Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 163. China Drug Detection and Analysis Market Size by Application (2027-2032) & (US$ Million) Table 164. Asia Drug Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 165. Asia Drug Detection and Analysis Market Size by Type (2027-2032) & (US$ Million) Table 166. Asia Drug Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 167. Asia Drug Detection and Analysis Market Size by Application (2027-2032) & (US$ Million) Table 168. Asia Drug Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Drug Detection and Analysis Market Size by Country (2021-2026) Table 170. Asia Drug Detection and Analysis Market Size by Country (2027-2032) Table 171. South America, Middle East & Africa Drug Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 172. South America, Middle East & Africa Drug Detection and Analysis Market Size by Type (2027-2032) & (US$ Million) Table 173. South America, Middle East & Africa Drug Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 174. South America, Middle East & Africa Drug Detection and Analysis Market Size by Application (2027-2032) & (US$ Million) Table 175. South America, Middle East & Africa Drug Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. South America, Middle East & Africa Drug Detection and Analysis Market Size by Country (2021-2026) Table 177. South America, Middle East & Africa Drug Detection and Analysis Market Size by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Drug Detection and Analysis Product Image Figure 2. Global Drug Detection and Analysis Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Drug Detection and Analysis Market Share by Type: 2025 VS 2032 Figure 4. Chemical Drug Testing Image Figure 5. Biopharmaceutical Testing Image Figure 6. Traditional Chinese Medicine Testing Image Figure 7. Others Image Figure 8. Global Drug Detection and Analysis Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Drug Detection and Analysis Market Share by Application: 2025 VS 2032 Figure 10. Pharmaceutical Companies Image Figure 11. Biopharmaceutical Companies Image Figure 12. Drug Regulatory Authorities Image Figure 13. Others Image Figure 14. Global Drug Detection and Analysis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 16. Global Drug Detection and Analysis Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Drug Detection and Analysis Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Drug Detection and Analysis Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Drug Detection and Analysis Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Drug Detection and Analysis Revenue Market Share by Type (2021-2032) Figure 23. Global Drug Detection and Analysis Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Drug Detection and Analysis Revenue Market Share by Application (2021-2032) Figure 25. North America Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 26. North America Drug Detection and Analysis Market Share by Type (2021-2032) Figure 27. North America Drug Detection and Analysis Market Share by Application (2021-2032) Figure 28. North America Drug Detection and Analysis Market Share by Country (2021-2032) Figure 29. United States Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 30. Canada Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 32. Europe Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 33. Europe Drug Detection and Analysis Market Share by Type (2021-2032) Figure 34. Europe Drug Detection and Analysis Market Share by Application (2021-2032) Figure 35. Europe Drug Detection and Analysis Market Share by Country (2021-2032) Figure 36. Germany Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 37. France Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 39. Italy Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 40. Russia Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 42. China Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 43. China Drug Detection and Analysis Market Share by Type (2021-2032) Figure 44. China Drug Detection and Analysis Market Share by Application (2021-2032) Figure 45. Asia Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 46. Asia Drug Detection and Analysis Market Share by Type (2021-2032) Figure 47. Asia Drug Detection and Analysis Market Share by Application (2021-2032) Figure 48. Asia Drug Detection and Analysis Market Share by Country (2021-2032) Figure 49. Japan Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 53. India Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 54. Australia Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Drug Detection and Analysis Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Drug Detection and Analysis Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Drug Detection and Analysis Market Share by Country (2021-2032) Figure 59. Brazil Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 64. UAE Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 66. Chile Drug Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical Drug Testing
  • Biopharmaceutical Testing
  • Traditional Chinese Medicine Testing
  • Others
Applications
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Drug Regulatory Authorities
  • Others
Companies covered
  • Eurofins Scientific
  • SGS
  • Labcorp
  • Intertek
  • WuXi AppTec
  • Charles River Laboratories
  • ICON pIc
  • IQVIA
  • Medpace
  • Syneos Health
  • Frontage Laboratories
  • Pace Analytical Services
  • Element Materials Technology
  • ALS Limited
  • STERIS
  • LGC Limited
  • Almac Group
  • Catalent
  • Cambrex
  • Alcami
  • Toxikon
  • Boston Analytical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Drug Detection and Analysis Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Chemical Drug Testing
  5. 1.2.3 Biopharmaceutical Testing
  6. 1.2.4 Traditional Chinese Medicine Testing
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Drug Detection and Analysis Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Companies
  11. 1.3.3 Biopharmaceutical Companies
  12. 1.3.4 Drug Regulatory Authorities
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Drug Detection and Analysis Growth Trends by Region
  16. 1.5.1 Global Drug Detection and Analysis Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Drug Detection and Analysis Market Size by Region (2021-2026)
  18. 1.5.3 Drug Detection and Analysis Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Drug Detection and Analysis Market Dynamics
  1. 2.1 Drug Detection and Analysis Industry Trends
  2. 2.2 Drug Detection and Analysis Industry Drivers
  3. 2.3 Drug Detection and Analysis Industry Opportunities and Challenges
  4. 2.4 Drug Detection and Analysis Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Drug Detection and Analysis Revenue by Company (2021-2026)
  2. 3.2 Global Drug Detection and Analysis Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Drug Detection and Analysis Key Company Head office and Area Served
  4. 3.4 Global Drug Detection and Analysis Company, Product Type & Application
  5. 3.5 Global Drug Detection and Analysis Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Drug Detection and Analysis Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Drug Detection and Analysis Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Drug Detection and Analysis Tier 1, Tier 2, and Tier 3
4 Drug Detection and Analysis Market by Type
  1. 4.1 Global Drug Detection and Analysis Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Drug Detection and Analysis Market Size by Type (2021-2032)
  3. 4.3 Global Drug Detection and Analysis Market Size Share by Type (2021-2032)
5 Drug Detection and Analysis Market by Application
  1. 5.1 Global Drug Detection and Analysis Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Detection and Analysis Market Size by Application (2021-2032)
  3. 5.3 Global Drug Detection and Analysis Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Eurofins Scientific
  2. 6.1.1 Eurofins Scientific Company Information
  3. 6.1.2 Eurofins Scientific Business Overview
  4. 6.1.3 Eurofins Scientific Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Eurofins Scientific Drug Detection and Analysis Product Portfolio
  6. 6.1.5 Eurofins Scientific Recent Developments
  7. 6.2 SGS
  8. 6.2.1 SGS Company Information
  9. 6.2.2 SGS Business Overview
  10. 6.2.3 SGS Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 SGS Drug Detection and Analysis Product Portfolio
  12. 6.2.5 SGS Recent Developments
  13. 6.3 Labcorp
  14. 6.3.1 Labcorp Company Information
  15. 6.3.2 Labcorp Business Overview
  16. 6.3.3 Labcorp Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Labcorp Drug Detection and Analysis Product Portfolio
  18. 6.3.5 Labcorp Recent Developments
  19. 6.4 Intertek
  20. 6.4.1 Intertek Company Information
  21. 6.4.2 Intertek Business Overview
  22. 6.4.3 Intertek Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Intertek Drug Detection and Analysis Product Portfolio
  24. 6.4.5 Intertek Recent Developments
  25. 6.5 WuXi AppTec
  26. 6.5.1 WuXi AppTec Company Information
  27. 6.5.2 WuXi AppTec Business Overview
  28. 6.5.3 WuXi AppTec Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 WuXi AppTec Drug Detection and Analysis Product Portfolio
  30. 6.5.5 WuXi AppTec Recent Developments
  31. 6.6 Charles River Laboratories
  32. 6.6.1 Charles River Laboratories Company Information
  33. 6.6.2 Charles River Laboratories Business Overview
  34. 6.6.3 Charles River Laboratories Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Charles River Laboratories Drug Detection and Analysis Product Portfolio
  36. 6.6.5 Charles River Laboratories Recent Developments
  37. 6.7 ICON pIc
  38. 6.7.1 ICON pIc Company Information
  39. 6.7.2 ICON pIc Business Overview
  40. 6.7.3 ICON pIc Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 ICON pIc Drug Detection and Analysis Product Portfolio
  42. 6.7.5 ICON pIc Recent Developments
  43. 6.8 IQVIA
  44. 6.8.1 IQVIA Company Information
  45. 6.8.2 IQVIA Business Overview
  46. 6.8.3 IQVIA Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 IQVIA Drug Detection and Analysis Product Portfolio
  48. 6.8.5 IQVIA Recent Developments
  49. 6.9 Medpace
  50. 6.9.1 Medpace Company Information
  51. 6.9.2 Medpace Business Overview
  52. 6.9.3 Medpace Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Medpace Drug Detection and Analysis Product Portfolio
  54. 6.9.5 Medpace Recent Developments
  55. 6.10 Syneos Health
  56. 6.10.1 Syneos Health Company Information
  57. 6.10.2 Syneos Health Business Overview
  58. 6.10.3 Syneos Health Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Syneos Health Drug Detection and Analysis Product Portfolio
  60. 6.10.5 Syneos Health Recent Developments
  61. 6.11 Frontage Laboratories
  62. 6.11.1 Frontage Laboratories Company Information
  63. 6.11.2 Frontage Laboratories Business Overview
  64. 6.11.3 Frontage Laboratories Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Frontage Laboratories Drug Detection and Analysis Product Portfolio
  66. 6.11.5 Frontage Laboratories Recent Developments
  67. 6.12 Pace Analytical Services
  68. 6.12.1 Pace Analytical Services Company Information
  69. 6.12.2 Pace Analytical Services Business Overview
  70. 6.12.3 Pace Analytical Services Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Pace Analytical Services Drug Detection and Analysis Product Portfolio
  72. 6.12.5 Pace Analytical Services Recent Developments
  73. 6.13 Element Materials Technology
  74. 6.13.1 Element Materials Technology Company Information
  75. 6.13.2 Element Materials Technology Business Overview
  76. 6.13.3 Element Materials Technology Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Element Materials Technology Drug Detection and Analysis Product Portfolio
  78. 6.13.5 Element Materials Technology Recent Developments
  79. 6.14 ALS Limited
  80. 6.14.1 ALS Limited Company Information
  81. 6.14.2 ALS Limited Business Overview
  82. 6.14.3 ALS Limited Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 ALS Limited Drug Detection and Analysis Product Portfolio
  84. 6.14.5 ALS Limited Recent Developments
  85. 6.15 STERIS
  86. 6.15.1 STERIS Company Information
  87. 6.15.2 STERIS Business Overview
  88. 6.15.3 STERIS Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 STERIS Drug Detection and Analysis Product Portfolio
  90. 6.15.5 STERIS Recent Developments
  91. 6.16 LGC Limited
  92. 6.16.1 LGC Limited Company Information
  93. 6.16.2 LGC Limited Business Overview
  94. 6.16.3 LGC Limited Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 LGC Limited Drug Detection and Analysis Product Portfolio
  96. 6.16.5 LGC Limited Recent Developments
  97. 6.17 Almac Group
  98. 6.17.1 Almac Group Company Information
  99. 6.17.2 Almac Group Business Overview
  100. 6.17.3 Almac Group Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Almac Group Drug Detection and Analysis Product Portfolio
  102. 6.17.5 Almac Group Recent Developments
  103. 6.18 Catalent
  104. 6.18.1 Catalent Company Information
  105. 6.18.2 Catalent Business Overview
  106. 6.18.3 Catalent Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Catalent Drug Detection and Analysis Product Portfolio
  108. 6.18.5 Catalent Recent Developments
  109. 6.19 Cambrex
  110. 6.19.1 Cambrex Company Information
  111. 6.19.2 Cambrex Business Overview
  112. 6.19.3 Cambrex Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Cambrex Drug Detection and Analysis Product Portfolio
  114. 6.19.5 Cambrex Recent Developments
  115. 6.20 Alcami
  116. 6.20.1 Alcami Company Information
  117. 6.20.2 Alcami Business Overview
  118. 6.20.3 Alcami Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Alcami Drug Detection and Analysis Product Portfolio
  120. 6.20.5 Alcami Recent Developments
  121. 6.21 Toxikon
  122. 6.21.1 Toxikon Company Information
  123. 6.21.2 Toxikon Business Overview
  124. 6.21.3 Toxikon Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Toxikon Drug Detection and Analysis Product Portfolio
  126. 6.21.5 Toxikon Recent Developments
  127. 6.22 Boston Analytical
  128. 6.22.1 Boston Analytical Company Information
  129. 6.22.2 Boston Analytical Business Overview
  130. 6.22.3 Boston Analytical Drug Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Boston Analytical Drug Detection and Analysis Product Portfolio
  132. 6.22.5 Boston Analytical Recent Developments
7 North America
  1. 7.1 North America Drug Detection and Analysis Market Size (2021-2032)
  2. 7.2 North America Drug Detection and Analysis Market Size by Type
  3. 7.2.1 North America Drug Detection and Analysis Market Size by Type (2021-2026)
  4. 7.2.2 North America Drug Detection and Analysis Market Size by Type (2027-2032)
  5. 7.2.3 North America Drug Detection and Analysis Market Share by Type (2021-2032)
  6. 7.3 North America Drug Detection and Analysis Market Size by Application
  7. 7.3.1 North America Drug Detection and Analysis Market Size by Application (2021-2026)
  8. 7.3.2 North America Drug Detection and Analysis Market Size by Application (2027-2032)
  9. 7.3.3 North America Drug Detection and Analysis Market Share by Application (2021-2032)
  10. 7.4 North America Drug Detection and Analysis Market Size by Country
  11. 7.4.1 North America Drug Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Drug Detection and Analysis Market Size by Country (2021-2026)
  13. 7.4.3 North America Drug Detection and Analysis Market Size by Country (2027-2032)
  14. 7.4.4 North America Drug Detection and Analysis Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Drug Detection and Analysis Market Size (2021-2032)
  2. 8.2 Europe Drug Detection and Analysis Market Size by Type
  3. 8.2.1 Europe Drug Detection and Analysis Market Size by Type (2021-2026)
  4. 8.2.2 Europe Drug Detection and Analysis Market Size by Type (2027-2032)
  5. 8.2.3 Europe Drug Detection and Analysis Market Share by Type (2021-2032)
  6. 8.3 Europe Drug Detection and Analysis Market Size by Application
  7. 8.3.1 Europe Drug Detection and Analysis Market Size by Application (2021-2026)
  8. 8.3.2 Europe Drug Detection and Analysis Market Size by Application (2027-2032)
  9. 8.3.3 Europe Drug Detection and Analysis Market Share by Application (2021-2032)
  10. 8.4 Europe Drug Detection and Analysis Market Size by Country
  11. 8.4.1 Europe Drug Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Drug Detection and Analysis Market Size by Country (2021-2026)
  13. 8.4.3 Europe Drug Detection and Analysis Market Size by Country (2027-2032)
  14. 8.4.4 Europe Drug Detection and Analysis Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Drug Detection and Analysis Market Size (2021-2032)
  2. 9.2 China Drug Detection and Analysis Market Size by Type
  3. 9.2.1 China Drug Detection and Analysis Market Size by Type (2021-2026)
  4. 9.2.2 China Drug Detection and Analysis Market Size by Type (2027-2032)
  5. 9.2.3 China Drug Detection and Analysis Market Share by Type (2021-2032)
  6. 9.3 China Drug Detection and Analysis Market Size by Application
  7. 9.3.1 China Drug Detection and Analysis Market Size by Application (2021-2026)
  8. 9.3.2 China Drug Detection and Analysis Market Size by Application (2027-2032)
  9. 9.3.3 China Drug Detection and Analysis Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Drug Detection and Analysis Market Size (2021-2032)
  2. 10.2 Asia Drug Detection and Analysis Market Size by Type
  3. 10.2.1 Asia Drug Detection and Analysis Market Size by Type (2021-2026)
  4. 10.2.2 Asia Drug Detection and Analysis Market Size by Type (2027-2032)
  5. 10.2.3 Asia Drug Detection and Analysis Market Share by Type (2021-2032)
  6. 10.3 Asia Drug Detection and Analysis Market Size by Application
  7. 10.3.1 Asia Drug Detection and Analysis Market Size by Application (2021-2026)
  8. 10.3.2 Asia Drug Detection and Analysis Market Size by Application (2027-2032)
  9. 10.3.3 Asia Drug Detection and Analysis Market Share by Application (2021-2032)
  10. 10.4 Asia Drug Detection and Analysis Market Size by Country
  11. 10.4.1 Asia Drug Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Drug Detection and Analysis Market Size by Country (2021-2026)
  13. 10.4.3 Asia Drug Detection and Analysis Market Size by Country (2027-2032)
  14. 10.4.4 Asia Drug Detection and Analysis Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Drug Detection and Analysis Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Drug Detection and Analysis Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Drug Detection and Analysis Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Drug Detection and Analysis Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Drug Detection and Analysis Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Drug Detection and Analysis Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Drug Detection and Analysis Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Drug Detection and Analysis Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Drug Detection and Analysis Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Drug Detection and Analysis Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Drug Detection and Analysis Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Drug Detection and Analysis Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Drug Detection and Analysis Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Drug Detection and Analysis Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research